Foto del docente

Giovanni Brandi

Professore associato confermato

Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale

Settore scientifico disciplinare: MED/06 ONCOLOGIA MEDICA

Direttore Scuola di Specializzazione Oncologia Medica (DI 68/2015)

Pubblicazioni

G. Frega, O. Kepp, D. Turchetti, A. Rizzo, M.A. Pantaleo, G. Brandi, Hypothesis on the possible relevance of the immunogenic cell death in the treatment of gestational trophoblastic neoplasms, «TRANSLATIONAL ONCOLOGY», 2021, 14, pp. 1 - 3 [articolo]

Brandi G;Tavolari S;Guarnieri T;Di Marco M;Paterini P;Macchini M;Di Girolamo S;Papi A;De Rosa F;Biasco G, Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study., «PANCREAS», 2014, 43, pp. 53 - 63 [articolo]

Giovanni Brandi;Stefania Di Girolamo;Andrea Farioli;Francesco de Rosa;Stefania Curti;Antonio Daniele Pinna;Giorgio Ercolani;Francesco Saverio Violante;Guido Biasco;Stefano Mattioli, Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis, «CANCER CAUSES & CONTROL», 2013, 24, pp. 911 - 918 [articolo]

Di Marco M; Macchini M; Vecchiarelli S; Casadei R; Pezzilli R; Fanti S; Zanoni L; Calculli L; Barbieri E; Santini D; DI Cicilia R; Brandi G; Biasco G., Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases, «ONCOLOGY LETTERS», 2011, 2, pp. 195 - 200 [articolo]

Ercolani G; Zanello M; Grazi GL; Cescon M; Ravaioli M; Del Gaudio M; Vetrone G; Cucchetti A; Brandi G; Ramacciato G; Pinna AD, Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center, «JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES», 2010, 17, pp. 329 - 337 [articolo]

Ercolani G; Vetrone G; Grazi GL; Aramaki O; Cescon M; Ravaioli M; Serra C; Brandi G; Pinna AD, Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival., «ANNALS OF SURGERY», 2010, 252, pp. 107 - 114 [articolo]

Di Marco M; Di Cicilia R; Macchini M; Nobili E; Vecchiarelli S; Brandi G; Biasco G, Metastatic pancreatic cancer: is gemcitabine still the best standard treatment?, «ONCOLOGY REPORTS», 2010, 23, pp. 1183 - 1192 [articolo]

NANNINI M; NOBILI E;DI CICILIA R;BRANDI G; MALEDDU A; PANTALEO MA; BIASCO G, TO WIDEN THE SETTING OF CANCER PATIENTS WHO BENEFIT FROM METRONOMIC CAPECITABINE, «CANCER CHEMOTHERAPY AND PHARMACOLOGY», 2009, 64, pp. 189 - 193 [articolo]

Pantaleo MA.; Astolfi A.; Nannini M.; Paterini P.; Piazzi G.; Ercolani G.; Brandi G.; Martinelli G.; Pession A.; Pinna AD.; Biasco G., Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice, «BRITISH JOURNAL OF CANCER», 2008, 99, pp. 1729 - 1734 [articolo]

Pantaleo MA; Astolfi A; Nannini M; Paterini P; Piazzi G; Ercolani G; Brandi G; Maleddu A; Pinna AD; Pession A; Biasco G, Gene expression profiling of liver metastases from colorectal cancer: differencens between synchronous and metachronous lesions, in: Journal Of Clinical Oncology, «JOURNAL OF CLINICAL ONCOLOGY», 2008, 26, pp. 15062 - 15062 (atti di: 2008 ASCO annual meeting, Chicago, 2008 May 30- June 3) [atti di convegno-abstract]

Pantaleo MA;Nannini M;Lopci E;Castellucci P;Maleddu A;Lodi F;Nanni C;Allegri V;Astorino M;Brandi G;Di Battista M;Boschi S;Fanti S;Biasco G, Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases., «INTERNATIONAL JOURNAL OF ONCOLOGY», 2008, 33, pp. 443 - 452 [articolo]

Pantaleo MA; Astolfi A; Nannini M; Ercolani G; Brandi G; Fanello S; Formica S; De Giovanni C; Lollini PL; Pession A; Pinna AD; Biasco G, Gene expression profiling differences between synchronous and metachronous metastases of colorectal cancer., in: AACR 2007, 2007(atti di: AACR 2007, San Francisco, 2007) [atti di convegno-abstract]

R. Hakim; R. Poggi; M. Pantaleo; G. Benedetti; G. Brandi; G. Zannetti; M. Astorino; S. Fanello; S. Dell'arte; G. Biasco, Phase II study of temozolomide and celecoxib in the treatment of metastatic melanoma, «JOURNAL OF CLINICAL ONCOLOGY», 2006, 24, pp. 1815 - 1815 [abstract]